5,9,13-Pentadecatrien-2-one, 6,10,14-trimethyl-
Common Name: |
5,9,13-Pentadecatrien-2-one, 6,10,14-trimethyl- |
IUPAC Name: |
6,10,14-trimethylpentadeca-5,9,13-trien-2-one |
Molecular Formula: |
C18H30O |
SMILES: |
CC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C |
Inchi: |
1S/C18H30O/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19/h9,11,13H,6-8,10,12,14H2,1-5H3 |
Inchi Key: |
LTUMRKDLVGQMJU-UHFFFAOYSA-N |
Cas No: |
762-29-8 |
Name |
Value |
Lipinski Violations |
1 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
262.43 |
Mass (g/mol) |
262.23 |
Molar Refractivity |
87.42 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
9 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
19 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
302.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000009 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.61 |
LogP |
5.775 |
iLOGP |
3.67 |
XLOGP3 |
5.56 |
WLOGP |
5.77 |
MLOGP |
4.50 |
ESOL Log S |
-4.38 |
ESOL Solubility (mg/ml) |
0.011 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.68 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.47 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-3.95 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.461 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.945 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |